Master in Healthy Longevity (MHL)

Leading Change in Healthcare Through Increasing Healthspan

Overview

The Master in Healthy Longevity (MHL) at the NUS Yong Loo Lin School of Medicine is a postgraduate programme offered through two study pathways: a one-year full-time programme with on-site learning designed for recent graduates and early-career individuals, and a two-year part-time programme with blended learning tailored for working professionals.

The programme equips students with the knowledge and skills to contribute to the development of the Healthy Longevity ecosystem. Students will explore contemporary developments in geroscience, precision health, clinical trials, gerodiagnostics, gerotherapeutics, digital health and healthcare implementation.

Combining academic expertise, clinical infrastructure and translational research, the programme offers an approach to healthy longevity that goes beyond conventional ageing and gerontology studies. Graduates will be equipped to pursue opportunities across a range of sectors, including longevity and preventive health clinics, biotechnology and pharmaceutical research and development, supplements and nutraceuticals, digital health and health technology, and public health and policy.

Intake:

January 2027 (Professionals Cohort)

August 2027 (Early-Career Cohort)

Duration:

1 Year (Full-time)

2 Years (Part-time)

Application Dates:

January 2027 Intake
12 October 2026 – 19 November 2026

August 2027 Intake
1 December 2026 – 31 May 2027

Application Deadline:

12 November 2026

Outcome of Applications

30 November 2026

Ideal candidates for the programme

This programme is designed for established professionals and early-career individuals from diverse backgrounds, including medicine, dietetics, nursing, biomedical sciences, public health, business development, as well as those seeking to transition into the emerging field of Healthy Longevity Medicine.

As the global population ages and the burden of non-communicable diseases rises, there is a growing need for practitioners, researchers and innovators equipped with interdisciplinary knowledge and skills to address the biological, clinical and societal dimensions of ageing.

Graduates can pursue careers opportunities in sectors and organisations such as:

Programme Faculty

Prof J.J. (Hans) Meij PhD MBA

Co-Founder
NUS Academy for Healthy Longevity
NUS Yong Loo Lin School of Medicine

Prof Andrea Maier, MD PhD FRACP

Oon Chiew Seng Professor in Medicine,
Healthy Ageing and Dementia Research
NUS Academy for Healthy Longevity
NUS Yong Loo Lin School of Medicine

Dr Antoni Olona

Lecturer
NUS Academy for Healthy Longevity
NUS Yong Loo Lin School of Medicine

Asst Prof Pedro Carrera Bastos

Assistant Professor of Nutrition
Lisbon School of Medicine (FMUL)
Portugal

A/Prof Michael Dunn

Director of Education
Centre for Biomedical Ethics
NUS Yong Loo Lin School of Medicine

The MHL is available as a 1-year (full-time) or a 2-year (part-time) degree programme. Early-career individuals can choose between full-time and part-time study, both delivered through on-site learning, while working professionals follow a part-time pathway through blended learning.

Students can specialise in Geroscience (early-career cohort only), Geromedicine (both cohorts) or Innovation in Healthy Longevity (professional cohort only).

Students who complete all courses within the same track will graduate with that specialisation. However, specialisation is not a graduation requirement, and students may take courses across different tracks, provided they fulfil the required core and elective courses.

Graduation Requirements
Total Units Required: 40 Units

To graduate, students have to:

Complete 5 core courses (4 Units each, 20 Units in total)

    1. HLM5001 Foundations of Healthy Longevity
    2. HLM5002 Hallmarks of Ageing
    3. HLM5003 Gerodiagnostics
    4. HLM5004 Gerotherapeutics
    5. HLM5005 Building Healthy Longevity: Strategy and Ethics

+ Complete 2 specialisation electives (4 Units each, 8 Units in total)

Geroscience
(Early-career cohort only)

Geromedicine
(Both cohorts)

Innovation in Healthy Longevity
(Professional cohort only)

      • HLM5101 Preclinical Gerosciences
      • HLM5102 Clinical Trials in Gerosciences

      • HLM5201 Gerodiagnostics (Advanced)
      • HLM5202 Gerotherapeutics (Advanced)

      • HLM5301 Finance, Innovation and Policy in Healthy Longevity
      • HLM5302 Global Perspectives in Healthy Longevity: Demography, Policy and Implementation

+ Complete 1 elective from another specialisation (4 Units)

+ Complete either:

Capstone Project (8 Units)

OR

2 elective courses from the available electives and/or the cross-registered electives* (4 Units each, 8 Units in total)

*Mostly on-site

Relevant Certification Programmes

A portion of our master’s programme can be taken as a Graduate Certificate (GC), allowing students to acquire knowledge and skills pertinent to a specific topic in healthy longevity.

Upon successful completion of each certificate, students will be accredited with units that can be transferred toward the full master’s degree if they choose to complete the programme.

Graduate Certificates:

Graduate Certificates must be completed in sequence, beginning with the Graduate Certificate in Healthy Longevity, followed by Healthy Longevity Translation, before progressing to Geroscience, Geromedicine or Innovation in Healthy Longevity.

Stage 1

Graduate Certificate in Healthy Longevity • 12 Units

  • HLM5001 Foundations of Healthy Longevity
  • HLM5003 Gerodiagnostics
  • HLM5004 Gerotherapeutics

Stage 2

Graduate Certificate in Healthy Longevity Translation • 8 Units

  • HLM5002 The Hallmarks of Ageing
  • HLM5005 Building Healthy Longevity: Strategy and Ethics

Stage 3

Graduate Certificate in Geroscience
12 Units • Early-career cohort only

  • HLM5101 Preclinical Gerosciences
  • HLM5102 Clinical Trials in Gerosciences
  • Choose 1 between HLM5201 and HLM5202

Graduate Certificate in Geromedicine
12 Units

  • HLM5201 Gerodiagnostics (Advanced)
  • HLM5202 Gerotherapeutics (Advanced)
  • Early-career cohort: Choose 1 between HLM5101 and HLM5102
  • Professional cohort: Choose 1 between HLM5301 and HLM5302

Graduate Certificate in Innovation in Healthy Longevity
12 Units • Professional cohort only

  • HLM5301 Finance, Innovation and Policy in Healthy Longevity
  • HLM5302 Global Perspectives in Healthy Longevity: Demography, Policy and Implementation
  • Choose 1 between HLM5201 and HLM5202
Proposed Study Plan

Please refer HERE for the proposed study plan for full-time and part-time students.

Study Period

  • Full-time students are expected to complete the programme within 12 – 24 months. The maximum candidature is 24 months; excluding Leave of Absence (LOA).
  • Part-time students are expected to complete the programme within 24 – 48 months. The maximum candidature is 48 months; excluding Leave of Absence (LOA).

Important:

The University does not engage external agencies for student recruitment. Applicants should apply directly to the University and not through any agents. Applications submitted through agents will not receive any added advantage and the University reserves the right to reject such application without explanation.

Only online applications are accepted.

Before submitting your application:

To be eligible for enrolment, applicants must meet the following requirements. However, admission is competitive, and applicants with relevant industry experience will be considered favourably. Meeting the minimum requirements does not guarantee admission into the programme.

Minimum Requirements:

  • An MBBS, MBA, master’s degree or BSc (Hons) in a relevant field of science, medicine, public health or business.
  • For the professional cohort, applicants must have at least 5 years of relevant work experience in allied health, science, policymaking, consultancy, business or entrepreneurship within the health and wellness sectors.
  • Applicants with other qualifications and relevant experience may be considered on a case-by-case basis, subject to approval by the selection committee.
  • International applicants from non-English speaking universities must demonstrate English proficiency with a minimum TOEFL score of 85 (Internet-based) or a minimum IELTS Academic score of 6.0. All IELTS / TOEFL tests must have been taken not earlier than 3 years before the proposed date of admission.

Tuition Fees:

Total Tuition Fees (for students enrolled in the Academic Year 2027/2028 only): S$71,395.00 (inclusive of Goods & Services Tax (GST))

The payment schedule is as follows (inclusive of 9% GST):

Full-Time Students

Part-Time Students

International Students

Year 1 Semester 1

S$35,700.00

S$21,420.00
S$21,420.00
Year 1 Semester 2

S$35,695.00

S$14,280.00
S$14,280.00
Year 2 Semester 1
–
S$21,415.00
S$21,415.00

Year 2 Semester 2

–

S$14,280.00
S$14,280.00

Acceptance Fee (Including GST):

S$5,000.00

Additional Fee:
In addition to tuition fees, students will be charged miscellaneous student fees each semester.

Miscellaneous student fees help meet costs incurred by the University in providing services to the student community that are either not covered or only partially covered by the tuition fees. These services include healthcare for students; facilitating student cultural, social and recreational programmes; and maintaining the shuttle bus service, IT network and other essential campus infrastructure and services.

For more information, please visit the Office of the University Registrar website.

Note:
  • Tuition fees are subjected to annual review and inflation.
  • Upon acceptance of offer, an acceptance fee of S$5,000.00 (including GST) will be charged on the Graduate Admission System (GDA). Acceptance fees is non-refundable, non-transferable and will be credited towards the tuition fee once the programme starts.

The MHL is available as a 1-year (full-time) or a 2-year (part-time) degree programme. Early-career individuals can choose between full-time and part-time study, both delivered through on-site learning, while working professionals follow a part-time pathway through blended learning.

Students can specialise in Geroscience (early-career cohort only), Geromedicine (both cohorts) or Innovation in Healthy Longevity (professional cohort only).

Students who complete all courses within the same track will graduate with that specialisation. However, specialisation is not a graduation requirement, and students may take courses across different tracks, provided they fulfil the required core and elective courses.

Graduation Requirements
Total Units Required: 40 Units

To graduate, students have to:

Complete 5 core courses (4 Units each, 20 Units in total)

    1. HLM5001 Foundations of Healthy Longevity
    2. HLM5002 Hallmarks of Ageing
    3. HLM5003 Gerodiagnostics
    4. HLM5004 Gerotherapeutics
    5. HLM5005 Building Healthy Longevity: Strategy and Ethics

+ Complete 2 specialisation electives (4 Units each, 8 Units in total)

Geroscience
(Early-career cohort only)

      • HLM5101 Preclinical Gerosciences
      • HLM5102 Clinical Trials in Gerosciences

Geromedicine
(Both cohorts)

      • HLM5201 Gerodiagnostics (Advanced)
      • HLM5202 Gerotherapeutics (Advanced)

Innovation in Healthy Longevity
(Professional cohort only)

      • HLM5301 Finance, Innovation and Policy in Healthy Longevity
      • HLM5302 Global Perspectives in Healthy Longevity: Demography, Policy and Implementation

+ Complete 1 elective from another specialisation (4 Units)

+ Complete either:

Capstone Project (8 Units)

OR

2 elective courses from the available electives and/or the cross-registered electives* (4 Units each, 8 Units in total)

*Mostly on-site

Relevant Certification Programmes

A portion of our master’s programme can be taken as a Graduate Certificate (GC), allowing students to acquire knowledge and skills pertinent to a specific topic in healthy longevity.

Upon successful completion of each certificate, students will be accredited with units that can be transferred toward the full master’s degree if they choose to complete the programme.

Graduate Certificates:

Graduate Certificates must be completed in sequence, beginning with the Graduate Certificate in Healthy Longevity, followed by Healthy Longevity Translation, before progressing to Geroscience, Geromedicine or Innovation in Healthy Longevity.

Stage 1

Graduate Certificate in Healthy Longevity
12 Units

  • HLM5001 Foundations of Healthy Longevity
  • HLM5003 Gerodiagnostics
  • HLM5004 Gerotherapeutics

Stage 2

Graduate Certificate in Healthy Longevity Translation
8 Units

  • HLM5002 The Hallmarks of Ageing
  • HLM5005 Building Healthy Longevity: Strategy and Ethics

Stage 3

Graduate Certificate in Geroscience
12 Units • Early-career cohort only

  • HLM5101 Preclinical Gerosciences
  • HLM5102 Clinical Trials in Gerosciences
  • Choose 1 between HLM5201 and HLM5202

Graduate Certificate in Geromedicine
12 Units

  • HLM5201 Gerodiagnostics (Advanced)
  • HLM5202 Gerotherapeutics (Advanced)
  • Early-career cohort: Choose 1 between HLM5101 and HLM5102
  • Professional cohort: Choose 1 between HLM5301 and HLM5302

Graduate Certificate in Innovation in Healthy Longevity
12 Units • Professional cohort only

  • HLM5301 Finance, Innovation and Policy in Healthy Longevity
  • HLM5302 Global Perspectives in Healthy Longevity: Demography, Policy and Implementation
  • Choose 1 between HLM5201 and HLM5202
Proposed Study Plan

Please refer HERE for the proposed study plan for full-time and part-time students.

Study Period

  • Full-time students are expected to complete the programme within 12 – 24 months. The maximum candidature is 24 months; excluding Leave of Absence (LOA).
  • Part-time students are expected to complete the programme within 24 – 48 months. The maximum candidature is 48 months; excluding Leave of Absence (LOA).

Important:

The University does not engage external agencies for student recruitment. Applicants should apply directly to the University and not through any agents. Applications submitted through agents will not receive any added advantage and the University reserves the right to reject such application without explanation.

Only online applications are accepted.

Before submitting your application:

To be eligible for enrolment, applicants must meet the following requirements. However, admission is competitive, and applicants with relevant industry experience will be considered favourably. Meeting the minimum requirements does not guarantee admission into the programme.

Minimum Requirements:

  • An MBBS, MBA, master’s degree or BSc (Hons) in a relevant field of science, medicine, public health or business.
  • For the professional cohort, applicants must have at least 5 years of relevant work experience in allied health, science, policymaking, consultancy, business or entrepreneurship within the health and wellness sectors.
  • Applicants with other qualifications and relevant experience may be considered on a case-by-case basis, subject to approval by the selection committee.
  • International applicants from non-English speaking universities must demonstrate English proficiency with a minimum TOEFL score of 85 (Internet-based) or a minimum IELTS Academic score of 6.0. All IELTS / TOEFL tests must have been taken not earlier than 3 years before the proposed date of admission.

Tuition Fees:

Total Tuition Fees (for students enrolled in the Academic Year 2027/2028 only): S$71,395.00 (inclusive of Goods & Services Tax (GST))

The payment schedule is as follows (inclusive of 9% GST):

Year 1 Semester 1

Full-Time Students

S$35,700.00

Part-Time Students

S$21,420.00

International Students

S$21,420.00

Year 1 Semester 2

Full-Time Students

S$35,695.00

Part-Time Students

S$14,280.00

International Students

S$14,280.00

Year 2 Semester 1

Full-Time Students

–

Part-Time Students

S$21,415.00

International Students

S$21,415.00

Year 2 Semester 2

Full-Time Students

–

Part-Time Students

S$14,280.00

International Students

S$14,280.00

Acceptance Fee (Including GST):

S$5,000.00

Additional Fee:

In addition to tuition fees, students will be charged miscellaneous student fees each semester.

Miscellaneous student fees help meet costs incurred by the University in providing services to the student community that are either not covered or only partially covered by the tuition fees. These services include healthcare for students; facilitating student cultural, social and recreational programmes; and maintaining the shuttle bus service, IT network and other essential campus infrastructure and services.

For more information, please visit the Office of the University Registrar website.

Note:

  • Tuition fees are subjected to annual review and inflation.
  • Upon acceptance of offer, an acceptance fee of S$5,000.00 (including GST) will be charged on the Graduate Admission System (GDA). Acceptance fees is non-refundable, non-transferable and will be credited towards the tuition fee once the programme starts.

Frequently Asked Questions

No. The programme is designed for a multidisciplinary audience, including healthcare professionals, scientists, researchers, public health professionals, policymakers, entrepreneurs and industry leaders interested in healthy longevity.

The programme offers two cohorts: a professional cohort delivered through blended learning and an early-career cohort with fully on-site learning. Students in the professional cohort must attend all on-site sessions, which include lectures, networking opportunities, workshops and interactive activities that form an important part of the learning experience.
No. The professional cohort follows a blended learning format, combining mandatory on-site intensive weeks in Singapore with online learning. The early-career cohort is delivered fully on-site.

Assessments include a combination of tests, assignments, case-based analyses and presentations, with an emphasis on applying concepts and critically evaluating evidence.

The programme combines scientific foundations, practical applications and critical discussion. Learning includes lectures, case-based learning, group discussions, networking and translation into clinical, research, policy and entrepreneurial settings.

No. The programme is an academic qualification and does not provide a professional licence to practise medicine. Clinical practice requirements remain subject to the regulations of each country and professional licensing authority.

The Graduate Certificate provides foundational training, while the Master’s programme offers more advanced and specialised study with additional coursework and capstone requirements.

As the programme develops, opportunities for prospective students to interact with alumni may become available.

Yes. Healthy longevity is a rapidly growing field that requires expertise beyond healthcare and research. Professionals from business, innovation, investment, consulting, technology and related sectors are encouraged to apply.

Yes. Students will gain advanced knowledge in geroscience, biomarkers of ageing, personalised nutrition, lifestyle gerotherapeutics and healthy longevity strategies that can complement and expand existing clinical nutrition practice.

If you are unable to find the answer to your query in the list of FAQs, you can email us at longevityacademy@nus.edu.sg and we will reply to you within 3 working days.

Voices That Inspire

Want to explore more of what we offer?

Top

Have Questions? Get in Touch with Us

    By submitting this form, you consent to the National University of Singapore (NUS) Yong Loo Lin School of Medicine collecting, using, and disclosing your business data, as provided in this form, for administrative and marketing purposes. For more information, please refer to our NUS Privacy Notice.

    Prof J.J. (Hans) Meij PhD MBA

    • Co-Founder, NUS Academy for Healthy Longevity, NUS Yong Loo Lin School of Medicine
    • Professor of Medicine, Dean’s Office, NUS Yong Loo Lin School of Medicine
    • CEO, Beyond100 (GEMS, Dubai)

    Professor Hans recently retired as Vice Dean International Affairs at Amsterdam UMC, but continues working as a medical anthropologist focused on Healthy Longevity. A pioneer in testing life history theory in Africa, he co-founded the Leyden Academy on Vitality and Aging (2008) and NUS Academy for Healthy Longevity (2022). In August 2026, he was appointed as chair and CEO of Dubai’s Beyond100 program on Healthy Longevity, reaching out to 170,000 young students in the Middle East.

    Prof Andrea Maier, MD PhD FRACP

    • Oon Chiew Seng Professor in Medicine, Healthy Ageing and Dementia Research, NUS Yong Loo Lin School of Medicine
    • Co-Founder and Director, NUS Academy for Healthy Longevity, NUS Yong Loo Lin School of Medicine
    • Chair @AgeGlobal
    • Professor of Gerontology, Vrije Universiteit Amsterdam, The Netherlands
    Professor Andrea B. Maier is Oon Chiew Seng Professor in Medicine at NUS Academy for Healthy Longevity and Professor of Gerontology at Vrije Universiteit Amsterdam. An internationally recognised authority in geroscience and precision geromedicine, she has authored over 500 peer-reviewed publications and co-founded the NUS Academy for Healthy Longevity.

    Dr Antoni Olona

    • Lecturer, NUS Academy for Healthy Longevity, NUS Yong Loo Lin School of Medicine
    • Lecturer, Department of Physiology, NUS Yong Loo Lin School of Medicine
    Dr Antoni Olona holds a PhD from Imperial College London, where he investigated immune lipid metabolism and its links to obesity. His postdoctoral research at Imperial College London and Duke-NUS focused on immune and nutrient pathways in infectious disease and ageing. Drawing on his research and teaching experience, he is now a Lecturer at the Academy, advancing education in healthy longevity.

    Asst Prof Pedro Carrera Bastos

    • Assistant Professor of Nutrition, Lisbon School of Medicine (FMUL), Portugal
    • Lecturer, European University of Madrid, Spain
    • Nutrition Researcher, Centre for Primary Health Care Research, Lund University, Sweden
    • International Lecturer
    Assistant Professor Pedro Carrera Bastos, PhD, is a nutritionist, researcher, and university lecturer affiliated with institutions in Portugal, Sweden, and Spain. His research explores chronic inflammation, healthy longevity, immune ageing, cardiometabolic health, and the effects of nutrition and lifestyle on chronic disease. He has authored over 50 scientific publications and teaches internationally.

    A/Prof Michael Dunn

    • Director of Education, Centre for Biomedical Ethics, NUS Yong Loo Lin School of Medicine
    Dr Michael Dunn is Associate Professor and Director of Education at the Centre for Biomedical Ethics, NUS Medicine. His research focuses on ethical issues in healthcare, ageing, decision-making, and health policy. An internationally recognised bioethicist, he has published over 100 scholarly works and leads educational initiatives in bioethics, health ethics, and professionalism.

    Walter C. Willett

    • Professor of Epidemiology and Nutrition, Department of Nutrition, Harvard T.H. Chan School of Public Health
    • Co-Chair, EAT-Lancet Commission
    • Director, Thich Nhat Hanh Center for Mindfulness in Public Health, Harvard T.H. Chan School of Public Health
    • Faculty Affiliate, Department of Epidemiology, Harvard T.H. Chan School of Public Health
    • Former Chair, Department of Nutrition, Harvard T.H. Chan School of Public Health
    • Elected Member, National Academy of Medicine, United States
    • Author, Nutritional Epidemiology
    • Member, MSc NLM Programme Curriculum Committee

    Walter C. Willett, a Professor of Epidemiology and Nutrition at Harvard T.H. Chan School of Public Health and a Director of the Thich Nhat Hanh Center for Mindfulness in Public Health. He served as Chair of the Department of Nutrition for 25 years. A globally recognised expert in nutritional epidemiology, his research on diet and chronic disease prevention has shaped public health policies worldwide. An elected member of the National Academy of Medicine, he has published over 2,000 scientific articles and authored influential books, including Nutritional Epidemiology.

    Adj Prof Joanne Yoong Su Yin

    • Adjunct Professor, NUS Yong Loo Lin School of Medicine
    • Founder and Chief Executive, Research for Impact, Singapore
    • Honorary Senior Lecturer, London School of Hygiene and Tropical Medicine
    • Adjunct Faculty, Department of Economics, Singapore Management University

    A/Prof Kenneth Ban

    Programme Director, National Supercomputing Cluster Singapore (NSCC)
    Assoc Prof, Dept of Biochemistry, NUS Yong Loo Lin School of Medicine

    Prof Kenneth Ban graduated from NUS Yong Loo Lin School of Medicine and completed his PhD in Stanford University, As a medical educator and Phase I Director at the Yong Loo Lin School of Medicine, Kenneth is leading the development of a Health Informatics track aiming to build foundational competencies in data science for medical students.

    A/Prof Caroline Lee

    Vice Dean, NUS Graduate School, NUS Yong Loo Lin School of Medicine
    Assoc Prof, Dept of Biochemistry, NUS Yong Loo Lin School of Medicine

    Prof Caroline Lee graduated with PhD from Baylor College of Medicine and did her post-doctoral training with Dr. Michael Gottesman at the National Cancer Institute, National Institutes of Health. She has ~100 peer reviewed publications focused on the functional genomics of hepatocellular carcinoma (HCC) and pharmacogenetics.

    Aaron Chua

    • Principal Lecturer and Consultant, Digital Strategy & Leadership Practice, NUS-ISS

    His research interests comprise health-related quality-of-life studies, clinical trials, and modelling transmission of infectious disease. He has also worked with projects in various therapeutic areas including oncology, stroke, ophthalmology and orthopaedics.

    A/Prof Jason Yap

    • Associate Professor, NUS Saw Swee Hock School of Public Health
    • Director, Public Health Translation, NUS Saw Swee Hock School of Public Health

    Prof Seth Gilbert

    • Dean’s Chair Associate Professor, NUS School of Computing
    • Head, Department of Computer Science, NUS School of Computing

    Adj. Prof Ngiam Kee Yuan

    • Head, Department of Biomedical Informatics, NUS Yong Loo Lin School of Medicine
    • Head, Artificial Intelligence Office, NUHS
    • Head & Senior Consultant, Division of General Surgery (Endocrine & Thyroid Surgery), Department of Surgery, NUH

    Dr Aoife Keohane

    • Programme Director, MSc in Behavioural and Implementation Sciences
    in Health (MSc BIS)
    • Senior Lecturer, Centre for Behavioural and Implementation
    Science Interventions (BISI) NUS Yong Loo Lin School of Medicine

    Prof Nick Sevdalis

    • Academic Director, Centre for Behavioural and Implementation Science Interventions (BISI)
    • Visiting Professor, Department of Psychological Medicine, NUS Yong Loo Lin School of Medicine
    • Academic Director (Joint), Quality Improvement & Implementation Science Clinical Academic Group, King’s Health Partners, London, UK

    Dr Volker Patzel

    • Biomedical Innovation & Enterprise Course Coordinator, MSc in Applied Biomedicine
    • Senior Lecturer, Department of Microbiology & Immunology, NUS Yong Loo Lin School of Medicine

    Dr Volker Patzel is a Senior Lecturer at NUS Yong Loo Lin School of Medicine and holds a PhD from the Ruprecht Karls University in Heidelberg. With more than 20 years of teaching experience, he coordinates six modules at NUS Yong Loo Lin School of Medicine and leads research on RNA technologies for therapeutic and diagnostic applications. Dr Patzel has published over 50 papers, filed 15 patent families, and founded AVECRIS Pte Ltd in Singapore.

    A/Prof Gautam Sethi

    • Drug Discovery and Development Specialisation Coordinator
    • Capstone Project Co-Coordinator, MSc in Applied Biomedicine
    • Associate Professor, Department of Pharmacology, NUS Yong Loo Lin School of Medicine

    A/Prof Gautam Sethi is a tenured Associate Professor at NUS Yong Loo Lin School of Medicine, focusing on oncogenic transcription factor activation and cancer therapy. His work has led to over 400 scientific publications in high-impact journals. A/Prof Sethi is an editorial board member for numerous international journals and has been recognized as one of the world’s most highly cited researchers in 2020 and 2021 by Clarivate.

    A/Prof Sham Lok-To (Chris)

    • Capstone Project Coordinator, MSc in Applied Biomedicine
    • Associate Professor, Department of Microbiology & Immunology, NUS Yong Loo Lin School of Medicine

    A/Prof Chris Sham is an Associate Professor at the Department of Microbiology & Immunology, NUS Yong Loo Lin School of Medicine, where he teaches multiple microbiology-related courses, including Microbiology and Infection and Immunity He also serves as the Undergraduate Research Opportunities Programme coordinator and the Deputy Research Director of the Infectious Diseases Translational Research Programme. His research focuses on bacterial cell envelope synthesis, and in 2019, he received the prestigious National Research Foundation Fellowship.

    Dr Png Chin Wen

    • Deputy Programme Director
    • Vaccinology and Immunotherapy Specialisation Coordinator, MSc in Applied Biomedicine
    • Senior Lecturer, Department of Microbiology & Immunology, NUS Yong Loo Lin School of Medicine

    Dr Png Chin Wen earned his PhD from the University of Queensland and is a Senior Lecturer at NUS Yong Loo Lin School of Medicine, where he teaches topics such as immunology, cellular signaling, and vaccine development. His research focuses on gut microbiome and mucosal inflammation related to gastrointestinal cancers. Dr Png collaborates with clinicians to explore the role of gut bacteria in disease progression and serves as course coordinator for the MSc in Applied Biomedicine’s Vaccinology and Immunotherapy specialisation.

    Dr Jaishree Tripathi

    • Infectious Diseases Management Specialisation Coordinator, MSc in Applied Biomedicine
    • Lecturer, Department of Microbiology & Immunology, NUS Yong Loo Lin School of Medicine

    Dr Jaishree Tripathi is a Lecturer at the NUS Yong Loo Lin School of Medicine, where she leads the Infectious Diseases Management track for the MSc in Applied Biomedicine programme. She has over 11 years of research experience in malaria parasite biology, including drug resistance and host-parasite interactions. Dr Tripathi holds a PhD in Biological Sciences from the University of Cambridge and has made significant contributions to malaria research using stem-cell-based models and single-cell transcriptomics.

    A/Prof Zhang Yongliang

    • Co-Programme Director, MSc in Applied Biomedicine
    • Associate Professor, Department of Microbiology & Immunology, NUS Yong Loo Lin School of Medicine

    A/Prof Zhang Yongliang is a tenured Associate Professor and Deputy Research Director of the Translational Immunology Programme at NUS Yong Loo Lin School of Medicine. With over 15 years of teaching experience, he has created several programmes focused on infection and cancer. A/Prof Zhang’s contributions to immunology research have earned him recognition, including the Graduate Mentor of the Year award in 2019.

    A/Prof Kevin Tan Shyong Wei

    • Programme Director, MSc in Applied Biomedicine
    • Associate Professor and Head, Department of Microbiology & Immunology, NUS Yong Loo Lin School of Medicine

    A/Prof Kevin Tan is the Head of the Department of Microbiology & Immunology at NUS and Vice-Dean (Graduate Studies) at the Yong Loo Lin School of Medicine. He has 20 years of teaching experience and played a key role in developing the world’s first online course on the biomedical aspects of COVID-19. A/Prof Tan has received numerous teaching awards, including the Faculty Teaching Excellence Award and Graduate Mentor of the Year.

    Dr Lee Chun Fan

    • Assistant Professor, Centre for Quantitative Medicine, Duke-NUS Medical School

    Dr Lee Chun Fan is an assistant professor at the Centre for Quantitative Medicine at the Duke-NUS Medical School. Prior to this, he was also affiliated with the Division of Epidemiology and Biostatistics in the School of Public Health at The University of Hong Kong and the Singapore Clinical Research Institute.
    His research interests comprise health-related quality-of-life studies, clinical trials, and modelling transmission of infectious disease. He has also worked with projects in various therapeutic areas including oncology, stroke, ophthalmology and orthopaedics.

    Dr Cindy Lin Xinyi

    • Assistant Professor, Centre for Quantitative Medicine, Duke-NUS Medical School

    Dr. Xinyi (Cindy) Lin is an Assistant Professor at the Centre for Quantitative Medicine, Duke- NUS Medical School. She serves as the course coordinator for two modular courses in in the MCI programme: MCI5001 (Design and Planning of Clinical Studies) and MCI5006 (Design and Planning of Epidemiological Studies). Dr. Lin has extensive experience utilising advanced statistical methods in clinical research studies and genetic epidemiology investigations. She has taught biostatistics coursework to a diverse audience, including PhD students and clinical researchers.

    Mihir Gandhi

    • Assistant Professor, Centre for Quantitative Medicine, Duke-NUS Medical School

    Mihir Gandhi is an Assistant Professor in the Signature Program in Health Services & Systems Research, Lien Centre for Palliative Care, as well as the Head of Biostatistics Core team at the Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore. He is also affiliated with the Singapore Clinical Research Institute, Singapore as the Head of Biostatistics Department and the Global Health Group at the Center for Child Health Research, Tampere University, Finland as a Visiting Researcher.
    He is primarily working on planning, analysis and reporting of clinical trials. He has experience in wide range of therapeutic areas such as oncology, paediatrics, and hypertension for drug and health services interventional trials. In addition to clinical trials, he has research interest in applied statistics, health-related quality of life, quality of healthcare and health state valuation.

    A/Prof Edwin Chan

    • Associate Professor, Centre for Quantitative Medicine
    • Office of Clinical Sciences, Duke-NUS Medical School

    A/Prof Chan is a clinical epidemiologist with over twenty years of experience in clinical research and evidence synthesis as the Chief Scientific Officer of the Singapore Clinical Research Institute (SCRI). He has been the Director of Cochrane Singapore since its establishment and is currently the Senior Scientific Advisor to SCRI. He teaches research literature critical appraisal skills and mentors students in clinical research (MCI programme, NUS). He has taught many research methodology courses on clinical trials, biostatistics, epidemiology, clinical practice guidelines (CPG) development, meta-analysis & evidence- based medicine (EBM). His interests are in the teaching of critical appraisal skills, epidemiology, health technology assessment and evidence synthesis.

    Prof Cheung Yin Bun

    • Professor, Centre for Quantitative Medicine
    • Deputy Director, Centre for Quantitative Medicine, Duke-NUS Medical School

    CHEUNG Yin Bun is Professor at Duke-NUS Medical School, Singapore, and Adjunct Professor at Tampere University, Finland. Prior to joining Duke-NUS, he was a Senior Lecturer at the London School of Hygiene & Tropical Medicine and Chief Scientific Officer at the Singapore Clinical Research Institute.
    He received his degrees in social science, medical demography, statistics and paediatric epidemiology from institutions in Hong Kong, Singapore, and the United Kingdom. He has broad interest in the studies of global child health, statistical methodology, and quality of life in palliative care setting. He has been the principal investigator of multiple research grants on statistical methodology and quality of life research. He is the author of Statistical Analysis of Human Growth and Development (CRC Press, 2014) and co-author of Survival Analysis: A Practical Approach (Wiley, 2006). He is the developer of the Singapore Caregiver Quality of Life Scale.

    Makoto Yawata, M.D., Ph.D.

    • Programme Director, Master of Clinical Investigation
    • Clinical-Scientist Mentor, Master of Clinical Investigation
    • Research Assistant Professor
    • Department of Pediatrics, NUS Yong Loo Lin School of Medicine
    • Principal Investigator, Immunology Programme, Life Sciences Institute, National University of Singapore
    • Principal Investigator, NUS Medicine Immunology Translational Research Programme, National University of Singapore

    Makoto YAWATA is the Director of the MCI Programme, where he also serves as a clinician-scientist mentor guiding the students in designing and planning their clinical studies and as coordinator of the MCI wet lab experiential research workshop. He is affiliated with the Department of Paediatrics at the NUS Yong Loo Lin School of Medicine and a Principal Investigator in the Immunology Programme in the NUS Life Sciences Institute and the NUS Medicine Immunology Translational Research Programme. 

    His clinical background is autoimmune diseases; however, the research he conducted as postdoctoral fellow in the Department of Structural Biology in Stanford University School of Medicine has led him to become more involved in hematology and transplantation. His laboratory has been investigating the mechanisms of human natural killer cell responses against particular types of virus infections and cancer, and also in transplantation immunology.